KR101884294B1 - Liquid tea compositions comprising dandelion and thistle root extract and Method of producing thereof - Google Patents
Liquid tea compositions comprising dandelion and thistle root extract and Method of producing thereof Download PDFInfo
- Publication number
- KR101884294B1 KR101884294B1 KR1020170089678A KR20170089678A KR101884294B1 KR 101884294 B1 KR101884294 B1 KR 101884294B1 KR 1020170089678 A KR1020170089678 A KR 1020170089678A KR 20170089678 A KR20170089678 A KR 20170089678A KR 101884294 B1 KR101884294 B1 KR 101884294B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- dandelion
- dried
- root
- thistle
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 239000007788 liquid Substances 0.000 title claims abstract description 24
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 20
- 239000000284 extract Substances 0.000 title claims description 72
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 title claims description 54
- 241000132536 Cirsium Species 0.000 title claims description 51
- 238000000034 method Methods 0.000 title claims description 15
- 240000001949 Taraxacum officinale Species 0.000 title description 2
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 47
- 235000008434 ginseng Nutrition 0.000 claims abstract description 22
- 241000245665 Taraxacum Species 0.000 claims description 52
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 39
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 21
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 21
- 238000004821 distillation Methods 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 12
- 230000032683 aging Effects 0.000 claims description 11
- 239000008213 purified water Substances 0.000 claims description 10
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 7
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 238000007865 diluting Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 4
- 240000004371 Panax ginseng Species 0.000 abstract description 18
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 15
- 230000003078 antioxidant effect Effects 0.000 abstract description 14
- 230000036541 health Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000729173 Cirsium japonicum Species 0.000 abstract 2
- 241000691199 Taraxacum platycarpum Species 0.000 abstract 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 32
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 32
- 229940010454 licorice Drugs 0.000 description 32
- 241001133760 Acoelorraphe Species 0.000 description 26
- 229930182490 saponin Natural products 0.000 description 14
- 150000007949 saponins Chemical class 0.000 description 14
- 235000017709 saponins Nutrition 0.000 description 14
- 235000013616 tea Nutrition 0.000 description 14
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 12
- 206010061218 Inflammation Diseases 0.000 description 10
- 230000004054 inflammatory process Effects 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 9
- 229940069445 licorice extract Drugs 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000002292 Radical scavenging effect Effects 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 6
- 239000002158 endotoxin Substances 0.000 description 6
- 229920006008 lipopolysaccharide Polymers 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004889 Interleukin-6 Human genes 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
- 229960003957 dexamethasone Drugs 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 241000233788 Arecaceae Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 2
- 241000218645 Cedrus Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000009120 camo Nutrition 0.000 description 2
- 235000005607 chanvre indien Nutrition 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 239000011487 hemp Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940100601 interleukin-6 Drugs 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 241000251169 Alopias vulpinus Species 0.000 description 1
- 244000208946 Arenga pinnata Species 0.000 description 1
- 235000006549 Arenga pinnata Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 1
- 108090000193 Interleukin-1 beta Proteins 0.000 description 1
- 102100035792 Kininogen-1 Human genes 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000020197 coconut milk Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000010981 drying operation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- -1 leukotrienes leukotriene Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000002864 mononuclear phagocyte Anatomy 0.000 description 1
- KNMNNEPMKDJBDW-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCNC(C)COC1=C(C)C=CC=C1C KNMNNEPMKDJBDW-UHFFFAOYSA-N 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 239000008149 soap solution Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 239000006200 vaporizer Substances 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/22—Drying or concentrating tea extract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/26—Homogenisation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/34—Membrane process
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 민들레와 엉겅퀴 뿌리를 이용한 액상 차 조성물 및 그 제조방법에 관한 것으로, 더욱 상세하게는 민들레, 엉겅퀴 뿌리 및 감초의 추출액을 유효성분으로 포함함으로써, 우수한 항염 및 항산화 활성을 갖는 민들레와 엉겅퀴 뿌리를 이용한 액상 차 조성물 및 그 제조방법에 관한 것이다. The present invention relates to a liquid tea composition using dandelion and thistle roots and a method for preparing the same. More particularly, the present invention relates to a liquid tea composition comprising dandelion and thistle roots And a method for producing the same.
최근 생활수준이 높아지고 식생활이 서구화되면서 영양과잉, 운동부족 등으로 인한 비만, 당뇨, 고혈압 및 심장병 등과 같은 생활 습관병(성인병) 발병이 높아지고 있다. 또한, 평균수명 연장으로 인한 노령화 사회로의 진입속도가 빨라지면서 건강증진에 대한 관심이 높아지고 있다.As the level of living has recently increased and the diet has become westernized, lifestyle-related diseases (adult diseases) such as obesity, diabetes, hypertension and heart disease due to over-nutrition and lack of exercise are increasing. In addition, as the average life span is extended, the rate of entry into the aging society is accelerating, and interest in health promotion is increasing.
이에 따라 홍삼, 글루코사민, 비타민 등을 이용한 건강 기능성 식품 수요가 늘고 있으며, 일상생활에서 즐겨 마시는 커피나 차(Tea)에서도 맛과 향이 좋을 뿐만 아니라 다이어트, 피부 미용, 노화억제, 해독작용, 면역력 증진, 특정 질병을 예방하거나 치료할 수 있는 성분이 함유된 기능성 차들이 주목받고 있다.As a result, the demand for health functional foods using red ginseng, glucosamine, vitamins, etc. is increasing, and coffee and tea, which are enjoyed in everyday life, are not only good in taste and aroma but also good in diet, skin care, aging suppression, detoxification, Functional vehicles containing ingredients capable of preventing or treating certain diseases have received attention.
한편, 염증반응(inflammation)은 생체 또는 조직에 물리적 작용, 화학적 물질, 세균감염 등의 기질적 변화를 가져오는 침습이 가해질 때 그 손상부위를 수복 재생하려는 기전이다. 일단 자극이 가해지면 국소적으로 히스타민(histamine), 세로토닌(serotonine), 브라디키닌(bradykinin), 프로스타글란딘(prostagladnins), 히드록실-에이코사테라에노이 산(hydorxyl-eicosatetraenoic acid, HETE) 및 류코트리엔(leukotriene)과 같은 혈관 활성물질이 유리되어 혈관 투과성이 증대되면서 단핵포식세포(mononuclear phagocytes), 대식세포(macrophage), 호중구(neutrophil), 자연살해세포(NK cell)가 손상부위로 침윤되어 염증을 유발하게 된다.On the other hand, inflammation is a mechanism to repair and regenerate the injured area when an invasion that causes physical changes such as physical action, chemical substance, and bacterial infection is applied to a living body or tissue. Once stimulated, local histamine, serotonine, bradykinin, prostagladnins, hydoroxyl-eicosatetraenoic acid (HETE), and leukotrienes leukotriene is released and vascular permeability is increased and mononuclear phagocytes, macrophages, neutrophils and NK cells infiltrate into injured areas and cause inflammation. .
감염이나 조직손상에 의해 발생하는 적당한 염증은 손상부위가 빠르게 회복되기 위한 정상적인 반응이다. 그러나 장기간에 걸친 지속적인 염증반응은 손상부위에 대한 회복을 지연시키고 주위 세포에 대한 상해를 동반하므로, 주변조직에 대한 방어력을 떨어뜨려 증세를 더욱 악화시킬 수 있어, 정상적인 염증반응을 유지하기 위한 항염증제제가 필요한 것이다. 현재 일반적으로 사용되는 대부분의 항염증제는 스테로이드계의 약물이나, 스테로이드계의 약물은 인체의 저항성을 약화시키거나 염증 부위의 조직재생을 지연시키는 부작용이 있어 대체약물의 개발이 필요하다.Appropriate inflammation caused by infection or tissue damage is a normal response to the rapid recovery of the injured site. However, the long-term continuous inflammation reaction may delay the recovery to the injured area and cause injury to the surrounding cells, which may deteriorate the defense against the surrounding tissues to further exacerbate the symptoms. Thus, an anti-inflammatory agent It is necessary. Most of the currently used anti-inflammatory drugs are steroid drugs, but steroid drugs have the side effects of weakening the resistance of the human body or delaying the tissue regeneration of inflammatory sites, and development of alternative drugs is needed.
따라서, 본 발명은 민들레, 엉겅퀴 뿌리, 감초의 추출액, 홍삼 추출액 및 팜 재거리 액을 사용하여, 풍미가 우수하면서도, 항산화, 항염증 효능이 우수한 기능성의 액상 차를 제공하는 데 그 목적이 있다.Accordingly, it is an object of the present invention to provide a functional liquid tea having excellent antioxidative and anti-inflammatory effects while having excellent flavor using dandelion, thistle root, licorice extract, red ginseng extract, and palm soap solution.
또한, 팜 재거리 액의 사용으로 홍삼과 민들레, 엉겅퀴 뿌리 및 감초 추출액의 쓴맛을 억제하는 데 그 목적이 있다.The purpose of this study was to suppress the bitter taste of red ginseng, dandelion, thistle root and licorice extract by using distilled water of palm.
상기한 목적을 달성하기 위한 본 발명의 민들레와 엉겅퀴 뿌리를 이용한 액상 차 조성물은, 민들레, 엉겅퀴 뿌리 및 감초의 추출액과, 홍삼 추출액과, 팜 재거리(palm jaggery) 액을 포함하는 것을 특징으로 한다.In order to accomplish the above object, the present invention provides a liquid tea composition using dandelion and thistle roots, which comprises an extract of dandelion, thistle root and licorice, a red ginseng extract, and a palm jaggery solution .
상기 민들레, 엉겅퀴 뿌리 및 감초의 추출액과, 상기 홍삼 추출액과, 상기 팜 재거리 액을 1:0.5~1.5:0.1~1 중량비로 포함하는 것을 특징으로 한다.The extract of dandelion, thistle root and licorice, the red ginseng extract, and the distillation solution of palm, in a weight ratio of 1: 0.5 to 1.5: 0.1 to 1.
상기 민들레, 엉겅퀴 뿌리 및 감초의 추출액은, 상기 민들레, 엉컹퀴 뿌리, 감초를 100:10~20:0.5~1 중량비로 혼합하고, 이를 추출하여서 된 것이고, 상기 홍삼 추출액은 수삼을 증삼, 건조 및 숙성하고, 이를 추출하여 된 것이며, 상기 팜 재거리 액은 팜 재거리를 정제수에 용해, 농축한 후, 필터로 거른 농축액을 희석하여 된 것임을 특징으로 한다. The extract of dandelion, thistle root and licorice is prepared by mixing the dandelion, tangy root and licorice at a ratio of 100: 10-20: 0.5-1, and extracting the extract. The ginseng extract is dried, The distillate is obtained by dissolving the palm material in purified water, concentrating the concentrate, and then diluting the concentrated concentrate with a filter.
그리고 그 제조방법은, 상기 혼합된 혼합물에 10~30중량배의 물을 가하고, 80~100℃에서 20~33시간 동안 추출하여 민들레, 엉겅퀴 뿌리 및 감초의 추출액을 수득하는 단계와, 수삼을 증삼기를 이용하여 70℃~125℃의 온도에서 90~220분간 증삼하고, 건조하는 단계와, 상기 건조된 삼을 4~10℃에서 6~12개월간 숙성하는 단계와, 상기 숙성된 삼에 10~~30중량배의 물을 가하고, 80~100℃에서 20~33시간 동안 추출하여 홍삼 추출액을 수득하는 단계와, 팜 재거리를 정제수에 용해, 농축한 후, 필터로 거르고, 이를 희석하여 팜 재거리 액을 수득하는 단계와, 상기 수득한 민들레, 엉겅퀴 뿌리 및 감초의 추출액과, 상기 홍삼 추출액과, 상기 팜 재거리 액을 90~100℃에서 혼합하는 단계를 포함하는 것을 특징으로 한다. The method comprises the steps of adding 10 to 30 times by weight of water to the mixed mixture and extracting the mixture at 80 to 100 ° C for 20 to 33 hours to obtain an extract of dandelion, thistle root and licorice; Aging at a temperature of 70 ° C to 125 ° C for 90 to 220 minutes and aging the dried sake at 4 to 10 ° C for 6 to 12 months; Adding 30 parts by weight of water and extracting at 80 to 100 ° C for 20 to 33 hours to obtain an extract of red ginseng; dissolving the palm material in purified water, concentrating it, filtering it with a filter, diluting it, And mixing the obtained extract of dandelion, thistle root and licorice, the red ginseng extract, and the distillation solution of palm at 90 to 100 캜.
상기 민들레, 엉겅퀴 뿌리, 감초를 100:10~20:0.5~1 중량비로 혼합하고, 상기 수득한 민들레, 엉겅퀴 뿌리 및 감초의 추출액과, 상기 홍삼 추출액과, 상기 팜 재거리 액을 1:0.5~1.5:0.1~1 중량비로 혼합하는 것을 특징으로 한다.The mixture of the above dandelion, thistle root and licorice in an amount of 100: 10-20: 0.5-1 weight ratio, the extract of dandelion, thistle root and licorice, the extract of red ginseng, 1.5: 0.1 to 1 by weight.
본 발명에 의하면, 항산화 및 항염증 효능이 우수하여 음용자의 건강을 증진시키는 장점이 있다. 또한, 관능성 역시 우수하여 남녀노소 누구나 음용이 가능하다는 장점이 있다. According to the present invention, there is an advantage in that the antioxidant and anti-inflammatory effects are excellent and the health of the consumer is improved. In addition, it is also excellent in sensory properties, so that it can be used by anyone, both young and old.
도 1은 본 발명에 따른 액상 차 조성물의 제조공정도.
도 2 내지 5는 본 발명의 시험예 2에 따른 결과를 나타낸 그래프.BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a process for producing a liquid phase composition according to the present invention. FIG.
2 to 5 are graphs showing the results according to Test Example 2 of the present invention.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 액상 차 조성물은 우수한 항산화 및 항염증 효능을 갖는 것으로, 차를 마시는 것만으로 인체에 우수한 항산화력 및 항염증력을 부여하여 음용자의 건강을 유지시키는 장점이 있다. INDUSTRIAL APPLICABILITY The liquid tea composition of the present invention has excellent antioxidative and antiinflammatory properties and is advantageous in that it provides excellent antioxidative and anti-inflammatory properties to the human body merely by drinking tea, thereby maintaining the health of the drinker.
이러한 본 발명의 액상 차 조성물은 민들레, 엉겅퀴 뿌리 및 감초의 추출액과 홍삼 추출액과 팜 재거리 액을 포함하는 것을 특징으로 한다.The liquid tea composition of the present invention is characterized by containing an extract of dandelion, thistle root and licorice, an extract of red ginseng and a distillate of palm.
먼저, 상기 민들레, 엉겅퀴 뿌리 및 감초의 추출액에 대해 설명한다.First, the extracts of the dandelion, thistle root and licorice will be described.
상기 민들레는 하얀 민들레의 전초를 건조한 것을 의미하는바, 이러한 민들레는 예로부터 한방에서 봄과 여름에 꽃이 피기 전이나 후에 채취하여 청열해독, 소염, 이뇨의 목적으로 이용하는 포공영이라는 약물로 이용되어 왔다. This dandelion means that the outpast of the white dandelion has been dried, and such dandelion has been used as a drug of Poeongyong which is used for the purpose of detoxification, inflammation and diuretic, .
그리고 상기 엉겅퀴 뿌리 역시 건조한 엉겅퀴의 뿌리를 의미하는 것으로, 상기 엉겅퀴 뿌리에는 다량의 실리마린이 포함되어 간에 우수한 작용을 나타냄이 알려져 왔다.The thistle root also means dried root of thistle. It has been known that the thistle root contains a large amount of silymarin and shows excellent action in the liver.
또한, 상기 감초는 감초의 뿌리를 건조한 것으로, 단맛을 가져 추출물의 맛을 개선하는 것은 물론, 향균, 항염증의 효과가 있음이 알려져 왔다.In addition, it has been known that the licorice root has dry roots of licorice root, has sweetness, has an effect of improving antibacterial and anti-inflammatory properties as well as improving the taste of the extract.
본 발명에서는 상기 민들레, 엉겅퀴 뿌리 및 감초를 함께 추출한 추출액을 유효성분으로 포함하는바, 이러한 3종의 추출액을 이용할 경우 각각을 단독으로 추출하여 이용할 때보다 그 항염 및 항산화 효과가 월등히 우수하기 때문이다.In the present invention, the extract containing the dandelion, thistle root and licorice together is used as an active ingredient. When these three kinds of extracts are used, their anti-inflammatory and antioxidative effects are far superior than those obtained by extracting them individually .
이때, 그 배합비는 민들레, 엉컹퀴 뿌리, 감초를 100:10~20:0.5~1 중량비로 혼합하고, 이를 추출하는 것인바, 이에 대해서는 하기 제조방법에서 더욱 상세히 설명한다.At this time, the blending ratio of the dandelion, the chrysanthemum root, and the licorice is 100: 10-20: 0.5-1 weight ratio, and the mixture is extracted, which will be described in more detail in the following production method.
그리고 상기 홍삼 추출액은 이미 많이 알려진 바와 같이, 사포닌, 플라보노이드 등의 유효성분으로 인해 인체에 유익한 효과를 가져다주는 것으로, 수삼을 증삼, 건조 및 숙성하고, 이를 추출하여 된 것이다. 상기 홍삼 추출액은 그 쓴맛으로 인해 어린아이나 성인들에게 거부감을 주나, 홍삼 특유의 향과 맛은 우수하다. As is well known, the above-mentioned red ginseng extract has a beneficial effect on the human body due to active ingredients such as saponin and flavonoid, and it is obtained by extracting, ginseng, dried and aged ginseng. The red ginseng extract gives a sense of rejection to children and adults due to its bitter taste, but it has excellent aroma and flavor unique to red ginseng.
또한, 상기 홍삼 추출액은 숙성과정을 통해 고분자의 사포닌을 저분자의 사포닌으로 전환하여 사포닌의 체내 흡수율을 높인 것으로, 이에 대해서는 하기 제조방법에서 더욱 상세히 설명한다.In addition, the red ginseng extract converts saponin of a polymer into saponin of low molecular weight through aging process to increase saponin absorption rate in the body, which will be described in more detail in the following production method.
상기 팜 재거리(Palm Jaggery) 액은 팜 재거리를 정제수에 용해하여 농축, 정제한 것을 다시 희석한 것이다. 여기서, 상기 팜재거리란 사탕수수가 아닌 야자의 수액을 증류하여 만든 원당으로서, 미네랄이 설탕에 비해 60배가 넘게 함유되어 있을 뿐 아니라, 칼슘, 철 등의 영양소도 풍부하다. 특히 팜 재거리는 정제된 설탕에 비해 복잡한 구조를 가지기 때문에 체내 흡수율이 낮고 흡수 역시 더디게 일어난다. 따라서, 오랜 시간에 걸쳐 천천히 에너지를 공급하므로 혈당량 조절이 용이한 장점이 있다. 상기 팜 재거리는 국가별로 토디팜 재거리, 슈가팜 재거리, 종려나무 수액 등으로 호칭되는데, 본 발명에서는 팜 재거리로서 통칭한다.The Palm Jaggery solution was prepared by dissolving the palm material in purified water, concentrating and purifying it again. Here, the palm street is a raw sugar made by distilling coconut milk, which is not sugar cane. It contains not less than 60 times of minerals than sugar, and also contains nutrients such as calcium and iron. In particular, the distances of the palms have a complex structure compared to the purified sugar, resulting in a low absorption rate and a slow absorption rate. Therefore, since the energy is slowly supplied over a long period of time, the blood glucose level can be easily controlled. The distances of the palms are referred to as Todi Palm distances, Sugar palm distances, and Palm tree sap for each country. In the present invention, they are collectively referred to as Palm distances.
따라서, 본 발명에서는 민들레, 엉겅퀴 뿌리 및 감초의 추출액과, 홍삼 추출액과, 팜 재거리(palm jaggery) 액을 모두 포함함으로써, 민들레, 엉겅퀴 뿌리 및 감초의 추출액을 통해 항염 및 항염증 효과를 현저히 높이고, 홍삼 추출액을 통해 각종 기능성을 부여하며, 상기 팜 재거리 액으로 단맛을 가미하고, 민들레, 엉겅퀴 뿌리 및 감초와 홍삼 특유의 쓴맛을 순화시키며, 홍삼 내 사포닌의 체내 흡수율을 높임으로써, 섭취자의 건강증진에 도움을 준다.Therefore, in the present invention, the anti-inflammatory and anti-inflammatory effects are remarkably enhanced through the extract of dandelion, thistle root and licorice by including the extract of dandelion, thistle root and licorice, red ginseng extract and palm jaggery And various functionalities are imparted through the red ginseng extract. The sweetness is added to the distillation liquid of palm, and the bitter taste of dandelion, thistle root, licorice and red ginseng is purified, and the absorption of saponin in red ginseng is increased, It helps to promote.
여기서, 상기 민들레, 엉겅퀴 뿌리 및 감초의 추출액과, 상기 홍삼 추출액과, 상기 팜 재거리 액의 혼합비는, 1:0.5~1.5:0.1~1 중량비인 것이 바람직한바, 상기한 배합비를 벗어날 경우 최적의 항염 및 항산화 효과를 가질 수 없는 것은 물론, 각종 기능성 역시 약화되기 때문이다.The mixing ratio of the extract of dandelion, thistle root and licorice, the red ginseng extract, and the distillation solution is preferably 1: 0.5 to 1.5: 0.1 to 1 by weight, Not only can not have anti-inflammatory and antioxidant effects, but also various functionalities are weakened.
이하, 그 제조방법에 대해 설명한다.Hereinafter, the production method thereof will be described.
본 발명에 따른 액상 차의 제조방법은 도 1과 같이, 상기 혼합된 혼합물에 10~30중량배의 물을 가하고, 80~100℃에서 20~33시간 동안 추출하여 민들레, 엉겅퀴 뿌리 및 감초의 추출액을 수득하는 단계와, 수삼을 증삼기를 이용하여 70℃~125℃의 온도에서 90~220분간 증삼하고, 건조하는 단계와, 상기 건조된 삼을 4~10℃에서 6~12개월간 숙성하는 단계와, 상기 숙성된 삼에 10~~30중량배의 물을 가하고, 80~100℃에서 20~33시간 동안 추출하여 홍삼 추출액을 수득하는 단계와, 팜 재거리를 정제수에 용해, 농축한 후, 필터로 걸르고, 이를 희석하여 팜 재거리 액을 수득하는 단계와, 상기 수득한 민들레, 엉겅퀴 뿌리 및 감초의 추출액과, 상기 홍삼 추출액과, 상기 팜 재거리 액을 90~100℃에서 혼합하는 단계를 포함하는 것을 특징으로 한다. As shown in FIG. 1, 10 to 30 times by weight of water is added to the mixed mixture and the mixture is extracted at 80 to 100 ° C for 20 to 33 hours to obtain an extract of dandelion, thistle root and licorice Drying the dried ginseng at 70 to 125 ° C. for 90 to 220 minutes using a steamer and drying the dried ginseng at 4 to 10 ° C. for 6 to 12 months; Adding 10 to 30 times by weight of water to the aged pellets and extracting at 80 to 100 ° C for 20 to 33 hours to obtain a red ginseng extract; dissolving the palm material in purified water, Mixing the extract of the dandelion, thistle root and licorice, the extract of red ginseng, and the distillate of palm at 90 to 100 ° C .; .
이를 단계별로 설명하면 다음과 같다.The following is a step-by-step explanation.
민들레, 엉겅퀴 뿌리 및 감초를 혼합하는 단계.Mixing dandelion, thistle root and licorice.
먼저, 항염 및 항산화 효과가 우수한 민들레, 엉겅퀴 뿌리 및 감초를 깨끗이 세척하여 혼합한다.First, dandelion, thistle root, and licorice, which have excellent anti-inflammatory and antioxidant properties, are thoroughly washed and mixed.
여기서, 상기 민들레란 하얀 민들레의 전초(잎과 뿌리를 포함)를 건조한 것을 의미하며, 엉겅퀴 뿌리 역시 엉겅퀴의 뿌리를 건조한 것을, 감초 역시 감초의 뿌리를 건조한 것을 의미한다.Here, the dandelion means that the outpost of the white dandelion (including the leaves and roots) is dried, the thistle root also has dried the root of the thistle, and the licorice also means that the root of licorice is dried.
이때, 상기 민들레, 엉겅퀴 뿌리 및 감초를 100:10~20:0.5~1 중량비로 혼합하는 것으로, 상기한 혼합비를 벗어날 경우 항염, 항산화 효과가 저하되기 때문이다.At this time, the dandelion, thistle root and licorice are mixed at a weight ratio of 100: 10 to 20: 0.5 to 1, so that the antimicrobial and antioxidative effect is lowered when the mixing ratio is out of the above range.
상기 혼합된 혼합물에 10~To the mixed mixture, 30중량배의30 times the weight of 물을 가하고, 80~100℃에서 20~33시간 동안 추출하여 민들레, 엉겅퀴 뿌리 및 감초의 추출액을 수득하는 단계. Water is added and extraction is carried out at 80 to 100 ° C for 20 to 33 hours to obtain an extract of dandelion, thistle root and licorice.
다음으로, 상기 혼합물에 혼합물 대비 10~30중량배의 물을 가하고, 80~100℃에서 20~33시간 동안 추출하여 그 추출액을 수득한다. Next, water is added to the mixture in an amount of 10 to 30 times by weight of the mixture, and the mixture is extracted at 80 to 100 ° C for 20 to 33 hours to obtain an extract.
여기서, 상기 추출액을 냉각 및 여과하는 것은 당연한바, 이러한 냉각 및 여과의 방법은 통상의 방법에 따르며, 필요에 따라 추출액을 농축할 수도 있음은 당연하다.Here, it is natural that the extract is cooled and filtered. It is natural that the cooling and filtration are performed according to a conventional method, and the extract can be concentrated if necessary.
또한, 상기 가열방법 역시 제한하지 않는 것인바, 직접 가열은 물론, 중탕과 같이 간접 가열 방법을 이용할 수도 있음은 당연하다.In addition, the heating method is not limited, and it is of course possible to use an indirect heating method such as hot water as well as direct heating.
수삼을 Fresh ginseng 증삼기를Thresher 이용하여 70℃~125℃의 온도에서 90~220분간 At a temperature of 70 ° C to 125 ° C for 90 to 220 minutes 증삼하고To boil , 건조하는 단계., Drying step.
상기 민들레, 엉겅퀴 뿌리 및 감초의 추출액의 제조와는 별도로, 3~6년근인 수삼을 준비하여 깨끗이 세척한다. Separately from the preparation of the dandelion, thistle root and licorice extract, 3 to 6 years old fresh ginseng is prepared and cleaned.
그리고 상기 수삼의 물기를 제거한 후, 증삼기를 이용하여 증삼한다. 이때, 상기 증삼의 조건은 70~125℃의 온도에서 90~220분간 증삼하는 것이 바람직한바, 증삼 온도가 70℃ 미만일 경우 홍삼화 진행이 느려 증삼 시간이 길어지며, 125℃를 초과할 경우 에너지가 낭비되기 때문이며, 증삼 시간이 90분 미만이면 수삼의 유효 성분들이 충분한 열분해 과정을 거치지 못해 인체에 유익한 성분이 충분히 생성되지 못하고, 220분을 초과하여도 더 이상의 홍삼화가 진행되지 않기 때문에 효율성이 떨어지기 때문이다. 여기서, 증삼기 내의 수증기의 압력은 1~3kg/㎠ 정도임이 바람직하다.After the water of the ginseng is removed, it is steamed using a steamer. At this time, it is preferable that the steamed ginseng is steamed at a temperature of 70 to 125 ° C for 90 to 220 minutes. When the steamed ginseng temperature is lower than 70 ° C, the red ginseng process is slow and the steaming time is prolonged. If the ginseng time is less than 90 minutes, the active ingredients of the ginseng do not undergo sufficient pyrolysis process, so that the beneficial ingredients for the human body can not be sufficiently produced. Further, since the red ginseng does not proceed further for more than 220 minutes, Because. Here, the pressure of water vapor in the vapor phase is preferably about 1 to 3 kg /
그리고 상기 증삼기 내의 수삼을 증삼 후 바로 꺼내지 않고, 20~50분간 더 방치하여 뜸을 들인다. 이는 증삼기에 별도의 열을 가하지 않으면서 증삼된 삼을 그대로 방치하는 것으로, 증삼된 삼을 그대로 꺼낼 경우 삼의 형태가 변형되거나 터지기 때문에 후공정이 효율적으로 이루어지지 않기 때문이다. 또한, 뜸들이는 과정을 통해 삼의 전분이 충분히 호화되도록 하기 위함이다.Then, the fresh ginseng in the ginseng stage is left for 20 to 50 minutes without taking it out immediately after boiling, and the ginseng is steamed. This is because the steamed steam is left as it is without adding any heat to the steam steam, and if the steam steamed steam is taken out as it is, the post-processing is not performed efficiently because the steam steam is transformed or exploded. It is also intended to ensure that the starch of cedar is sufficiently luxurious through the process of tumbling.
다음으로, 상기 증삼기 내의 삼을 꺼낸 후, 이를 건조기를 이용하여 건조한다. 상기 건조조건은 65~70℃로 20~30시간 건조하는 것인바, 건조온도가 65℃보다 낮을 경우 건조시간이 길어지고, 70℃를 초과할 경우 효율적이지 못하기 때문이다. 상기 건조기 내에서의 건조작업을 통해 증삼된 삼의 수분함량이 35~40% 정도가 된다.Next, after removing the inside of the vaporizer, it is dried using a drier. If the drying temperature is lower than 65 ° C, the drying time becomes longer. If the drying temperature is higher than 70 ° C, the drying time is not efficient. Through the drying operation in the dryer, the moisture content of the sesame seeds is about 35 to 40%.
그리고 상기 건조된 삼을 양건장으로 옮겨 재건조한다. 상기 양건장에서는 일조가 양호할 때에는 환기를 시켜 통풍이 잘되게 하고, 야간에는 필요에 따라 난방을 하여 삼이 충분히 건조되도록 한다. 그리고 균일한 건조를 위해 1일 2회 정도 뒤집기 작업을 실시한다.Then, the dried cedar is transferred to the amniotic membrane and dried again. When the sunshine is good in the amusement area, the air is ventilated to be well ventilated, and at night, the air is heated as needed to sufficiently dry the bed. In order to achieve a uniform drying, flip it twice a day.
상기 양건장에서의 건조기간은 제한하지 않으나, 삼의 최종 수분함유량이 12~18%가 되도록 건조한다.The drying period in the amphibian field is not limited, but the drying is performed so that the final moisture content of the hemp is 12 to 18%.
상기 건조된 삼을 4~10℃에서 6~12개월간 숙성하는 단계.Aging the dried snakes at 4-10 DEG C for 6-12 months.
상기와 같이 건조된 삼을 6~12개월간 숙성한다. 이러한 숙성을 통해 재건조된 삼 내의 고분자의 사포닌(R1,R2 등)을 저분자의 사포닌(R3, Rh2 등)으로 분해한다. 여기서, 상기 고분자의 사포닌은 상기 고분자의 사포닌은 체내에 사포닌 분해효소가 완전하게 갖춰진 경우에만 상기 고분자의 사포닌을 분해할 수 있고, 이를 통해 사포닌을 통한 홍삼의 효능을 향유할 수 있는 반면, 체내에 상기 사포닌 분해효소가 없거나, 불완전할 경우에는 위고분자의 사포닌을 분해할 수 없어 체내에 흡수되지 아니하므로 홍삼을 먹어도 효능이 없게 된다. 따라서, 본 발명은 상기 숙성과정을 통해 고분자의 사포닌을 미리 저분자로 분해함으로써, 체내에 사포닌 분해효소가 없더라도 유효 사포닌을 빠르게 흡수할 수 있도록 하는 것이다.The dried cakes are aged for 6 to 12 months. Through such aging, the saponins (R1, R2, etc.) of the polymer in the re-dried polymer are decomposed into low-molecular saponins (R3, Rh2, etc.). Herein, the saponin of the polymer can decompose the saponin of the polymer only when the saponin of the polymer is completely equipped with the saponin-decomposing enzyme in the body, and thereby can enjoy the efficacy of red ginseng through saponin, If the saponin-decomposing enzyme is absent or incomplete, the saponin of the polymer can not be decomposed, so that it can not be absorbed into the body, so that even when red ginseng is consumed, it becomes ineffective. Accordingly, in the present invention, the saponin of the polymer is previously decomposed into low molecular weight through the aging process, so that the saponin can be rapidly absorbed even if there is no saponin-decomposing enzyme in the body.
이때, 상기 숙성온도는 4~20℃ 정도임이 바람직하나, 가장 바람직하게는 4~10℃의 온도에서 숙성하는 것이다.At this time, the aging temperature is preferably about 4 to 20 ° C, and most preferably about 4 to 10 ° C.
상기 숙성된 삼에 10~The above- 30중량배의30 times the weight of 물을 가하고, 80~100℃에서 20~33시간 동안 추출하여 홍삼 추출액을 수득하는 단계. Adding water thereto, and extracting at 80 to 100 ° C for 20 to 33 hours to obtain an extract of red ginseng.
그리고 상기 숙성된 홍삼을 추출기로 추출한다. 상기 홍삼의 추출은 통상의 홍삼 추출기를 이용하는바, 홍삼에 10~30중량배의 물을 가하고, 80~100℃에서 20~33시간 동안 가열하여 추출, 냉각 및 여과함으로써, 홍삼 추출액을 수득한다. Then, the aged red ginseng is extracted with an extractor. The red ginseng extract is obtained by adding 10 to 30 times by weight of water to red ginseng and heating at 80 to 100 ° C for 20 to 33 hours to extract, cool and filter the red ginseng extract.
이때, 상기 가열방법은 제한하지 않는 것인바, 직접 가열은 물론, 중탕과 같이 간접 가열 방법을 이용할 수도 있음은 당연하다.At this time, the heating method is not limited, and it is of course possible to use an indirect heating method such as hot water as well as direct heating.
팜 Palm 재거리를Re-distance 정제수에In purified water 용해, 농축한 후, 필터로 After dissolution and concentration, 걸르고To go , 희석하여 팜 , Diluted to palm 재거리Distance 액을 수득하는 단계. Lt; / RTI >
다음으로, 상기 민들레, 엉겅퀴 뿌리, 감초의 추출액 및 홍삼의 추출액과는 별도로 팜 재거리 액을 제조한다.Next, a distillation liquid of palm is prepared separately from the above-mentioned dandelion, thistle root, licorice extract and extract of red ginseng.
상기 팜 재거리 액의 제조는 팜 재거리 100중량부를 기준으로 정제수 25~120중량부를 투입한 후, 온도가 50~70℃가 되도록 하여 30분~120분간 팜 재거리를 용해하고 농축한 후, 이를 필터로 걸러낸다. 그리고 필터로 걸러낸 60~75Brix의 농축액에 농축액 대비 물을 10~30중량배 가하고, 95~100℃로 가열하여 농축액을 희석하여 사용한다. 이러한 팜 재거리 액에 대한 설명은 대한민국 등록특허 제10-1438750호 등을 통해 충분히 공지된 사항으로, 이에 대한 상세한 설명은 생략한다. The distillation liquid of the distillery was prepared by dissolving and distilling the distillery for 30 to 120 minutes at a temperature of 50 to 70 ° C after adding 25 to 120 parts by weight of purified water based on 100 parts by weight of the distillery, Filter it with a filter. To the concentrate of 60 ~ 75Brix filtered by the filter, water is added 10 ~ 30 times as much as the concentrate, and the concentrate is diluted by heating at 95 ~ 100 ℃. The description of the distance of the palm distance is well known through Korean Registered Patent No. 10-1438750, and a detailed description thereof will be omitted.
한편, 상기 민들레, 엉겅퀴 뿌리, 감초의 추출액과 홍삼의 추출액 그리고 팜 재거리 액을 제조하는 단계를 순차적으로 설명하였지만, 그 순서를 제한하지 않는 것으로, 이는 각각 별도의 공정이므로, 공정의 효율성을 위하여 그 순서를 바꾸거나, 동시에 제조할 수 있음은 당연하다.Meanwhile, the steps of producing the dandelion, thistle root, licorice extract, extract of red ginseng, and distillation liquid of palm leaf have been sequentially described, but the order thereof is not limited. Since these are separate processes, It is natural that the order can be changed or manufactured at the same time.
상기 수득한 민들레, 엉겅퀴 뿌리 및 감초의 추출액과, 상기 홍삼 추출액과, 상기 팜 재거리 액을 90~100℃에서 혼합하는 단계.Mixing the extracted dandelion, thistle root and licorice extract, the red ginseng extract, and the distillation solution at 90 to 100 ° C.
그리고 최종적으로, 상기 수득한 민들레, 엉겅퀴 뿌리 및 감초의 추출액과, 상기 홍삼 추출액과, 상기 팜 재거리 액을 90~100℃에서 1:0.5~1.5:0.1~1 중량비로 혼합한다.Finally, the obtained extract of dandelion, thistle root and licorice, the extract of red ginseng and the distillate of palm are mixed at a temperature of 90 to 100 ° C at a ratio of 1: 0.5 to 1.5: 0.1 to 1.
상기와 같이 제조된 액상의 조성물은, 차는 물론, 음료로서 사용될 수 있는바, 뜨거운 물을 부어 음용할 경우는 차로서 사용되는 것이고, 이에 찬물을 가하거나, 뜨거운 차를 식혀 캔, PET 용기 등에 포장되어 유통될 경우 음료로서 사용되는 것이다.The liquid composition prepared as described above can be used not only as a tea but also as a beverage. When it is poured by pouring hot water, it is used as a tea, and cold water is added thereto. When it is distributed, it is used as a drink.
아울러, 본 발명에 따른 액상 조성물은 차로서 음용시, 액상 조성물과 물의 혼합량을 1:10~200 중량비 정도로 혼합할 수 있으나, 이는 개인의 기호도의 차이이므로, 취향에 따라 그 혼합량을 적절히 조절한다.When the liquid composition according to the present invention is used as a tea, the mixing amount of the liquid composition and water may be about 1: 10-200 weight ratio. However, the mixing amount of the liquid composition and the water is suitably adjusted according to preference.
이하, 구체적인 실시예를 통해 본 발명을 더욱 상세히 설명한다.Hereinafter, the present invention will be described in more detail with reference to specific examples.
(실시예 1)(Example 1)
민들레 건초, 건 엉겅퀴 뿌리, 건 감초를 준비하고, 이를 세척한 후, 물기를 제거하였다. 그리고 상기 민들레 건초 1kg, 건 엉겅퀴 뿌리 200g, 건 감초 5g을 혼합하고, 이에 36L의 물을 가한 후, 96℃에서 24시간 추출, 여과하여 민들레, 엉겅퀴 및 감초의 추출액을 수득하였다.Dandelion hay, dried thistle root, and dried licorice were prepared, washed, and then drained. 1 kg of dandelion hay, 200 g of thistle root, and 5 g of dried licorice were mixed, and 36 L of water was added thereto, followed by extraction at 96 캜 for 24 hours and filtration to obtain an extract of dandelion, thistle and licorice.
5년근 수삼을 깨끗이 세척한 후, 물기를 제거하고, 증삼기를 이용하여 100℃의 온도에서 3시간 동안 증삼하여 홍삼화하고, 30분간 증삼기 내에 방치하여 뜸을 들였다. 그리고 증삼된 삼을 꺼내 70℃로 24시간 건조하고, 건조된 삼을 양건장에서 재건조하여 최종 수분함유율이 15%가 되도록 하였다. 그리고 재건조된 삼을 12개월간 5℃에서 숙성하였다. 상기 숙성된 삼 1kg을 정제수 30L에 투입하여, 92~98℃에서 추출액을 추출, 여과하였다.After 5 years of fresh ginseng was cleaned, the water was removed, and red ginseng was added to the red ginseng for 3 hours at a temperature of 100 < 0 > C using a steamer. Then, it was dried at 70 ° C for 24 hours, and dried, and the dried cotton was re-dried in a cotton paddy field so that the final moisture content was 15%. The rehydrated hemp was aged at 5 ° C for 12 months. 1 kg of the aged saline was added to 30 L of purified water, and the extract was extracted at 92 to 98 ° C and filtered.
다음으로, 용기에 재거리 1kg과 50℃의 정제수 500g을 투입하고, 중탕을 통해 용기 내부 온도가 60℃가 되도록 하여 60분간 팜 재 거리를 용해, 농축하였다. 그리고 농축된 액을 면포를 이용하여 걸러냄으로써, 65~75Brix의 팜 재거리 액을 제조하였다. 그리고 이 농축액 1kg에 물 30L를 가하고, 98~100℃로 가열하여 희석하였다.Next, 1 kg of distillation water and 500 g of purified water of 50 캜 were added to the container, and the palm material distance was dissolved and concentrated for 60 minutes so that the inside temperature of the container became 60 캜 through a hot water bath. Then, the concentrated liquid was filtered using a cotton cloth to prepare a distillation solution of palm of 65 to 75 Brix. Then, 30 kg of water was added to 1 kg of this concentrate, and the mixture was diluted by heating at 98 to 100 ° C.
마지막으로, 상기 민들레, 엉겅퀴 뿌리 및 감초의 추출액, 홍삼 추출액, 팜 재거리 액의 최종 희석액을 90~100℃에서 1:1:1 중량비로 혼합하였다.Finally, the final dilutions of the dandelion, thistle root and licorice extract, red ginseng extract, and palm leaf distillate were mixed at 90 to 100 ° C at a weight ratio of 1: 1: 1.
(시험예 1)(Test Example 1)
항산화력 평가Antioxidant capacity evaluation
실시예 1과 같이 제조된 상기 민들레, 엉겅퀴 뿌리 및 감초의 추출액 및 홍삼 추출액의 항산화력을 평가하였다. 상기 각 추출액은 rotary vacuum evaporator(EYELAA-1000S, Tokyo Rikakikai Co., Tokyo, Japan)로 40℃에서 감압농축하여 건조시킨 후 냉동보관하면서 실험에 사용하였다.The antioxidative power of the dandelion, thistle root and licorice extract and red ginseng extract prepared as in Example 1 was evaluated. The extracts were concentrated under reduced pressure at 40 ° C on a rotary vacuum evaporator (EYELAA-1000S, Tokyo Rikakikai Co., Tokyo, Japan), dried and stored frozen and used in the experiment.
(1) DPPH radical 소거능 측정(1) Measurement of DPPH radical scavenging ability
항산화 활성 측정은 DDPH(1,1-diphenyl-2-picryhydrazyl, Sigma-Aldrich Co.)를 이용하여 시료의 라디칼 소거효과를 보는 Biois법을 활용하였다. 각 추출물을 농도별 0.025~10mg/ml로 제조한 시료 용액 1ml에 0.2mM DPPH 1ml를 넣고, vortex mixer를 사용하여 혼합하고 암실에서 30분간 반응시킨 후 517nm에서 흡광도를 측정하였다. 그리고 아래의 식을 이용하여 free radical scavenging activity 곡선을 작성한 후, IC50을 산출하였으며, 양성대조군으로 ascorbic acid를 사용하였다. To determine the antioxidant activity, the Biois method was used to examine the radical scavenging effect of DDPH (1,1-diphenyl-2-picryhydrazyl, Sigma-Aldrich Co.). 1 ml of 0.2 mM DPPH was added to 1 ml of the sample solution prepared from 0.025 to 10 mg / ml of each extract, mixed using a vortex mixer, reacted for 30 minutes in a dark room, and absorbance was measured at 517 nm. Then, free radical scavenging activity curves were generated using the following equation, and IC 50 was calculated. As a positive control, ascorbic acid was used.
Radical scavenging activity(%)={(control Absorbance - Sample Absorbance)/control Absorbance}×100Radical scavenging activity (%) = {(control Absorbance - Sample Absorbance) / control Absorbance} × 100
(2) ABTS radical 소거능 측정(2) Measurement of ABTS radical scavenging ability
ABTS radical 소거능 측정은 Pellegrin 등의 방법으로 측정하였다. 7mM ABTS(2,2'-azinobis(3-ethylenbenzothiazoline-6-sulfonate), Sigma-Aldrich Co.) 5ml와 140mM K2S2O8(Sigma-Aldrich Co.) 88㎕를 잘 섞어 16시간 이상 암소에 방치시켰다. ABTS radical scavenging activity was measured by Pellegrin et al. 5 ml of 7 mM ABTS (2,2'-azinobis (3-ethylenbenzothiazoline-6-sulfonate), Sigma-Aldrich Co.) and 88 μl of 140 mM K 2 S 2 O 8 (Sigma-Aldrich Co.) .
이를 absolute ethanol과 1:88 비율로 섞어 734nm에서 대조구의 흡광도 값이 0.7±0.002가 되도록 조절한 ABTS solution을 만들었다. 시료 용액 50㎕에 ABTS solution 1ml를 넣어 혼합하고, 2.5분간 암실에서 방치한 후, 734nm에서 흡광도를 측정하였다.The mixture was mixed with absolute ethanol at a ratio of 1:88, and the ABTS solution was prepared so that the absorbance of the control was adjusted to 0.7 ± 0.002 at 734 nm. 1 ml of ABTS solution was added to 50 μl of the sample solution, and the mixture was allowed to stand in a dark room for 2.5 minutes, and the absorbance was measured at 734 nm.
그 결과는 하기 표 1 및 표 2에 나타내었다.The results are shown in Tables 1 and 2 below.
(mg.ml)IC 50
(mg.ml)
(mg.ml)IC 50
(mg.ml)
상기 표 1, 2에서와 같이, 실시예 1에 따른 민들레, 엉겅퀴 뿌리 및 감초의 추출액의 항산화능은 홍삼 추출액에 비해서 현저히 우수함을 확인할 수 있었는바, 종래 기능성 차로서 활용되던 홍삼 추출액과 대비할 때 더욱 우수한 항염, 항산화 효과가 있을 것으로 기대되었다. As shown in Tables 1 and 2, the antioxidative activity of the extracts of dandelion, thistle root and licorice according to Example 1 was remarkably superior to that of the red ginseng extract. As a result, It was expected to have excellent anti-inflammatory and antioxidant effects.
(시험예 2)(Test Example 2)
항염증 효과.Anti-inflammatory effect.
실시예 1과 같이 제조된 상기 민들레, 엉겅퀴 뿌리 및 감초의 추출액의 항염증 효과를 측정하였다. The anti-inflammatory effect of the dandelion, thistle root and licorice extract prepared as in Example 1 was measured.
이때, 염증성 인자로는 Nitrite(혹은 일산화 산소), IL-1β(인터루킨-1베타, interleukin-1beta), IL-6(인터루킨-6, interleukin-6), TNF-α(종양괴사인자-알파, 혹은 tumor necrosis factor-alpha)를 사용하였다.IL-1β (interleukin-1beta), IL-6 (interleukin-6, interleukin-6) and TNF-α (tumor necrosis factor-alpha, Or tumor necrosis factor-alpha).
시험방법은, 대식세포(macrophage)에 LPS(lipopolysaccharide)를 이용하여 염증을 유발하고, 여기에 시료를 처리하였을 때의 일반적인 염증 지표들이 억제되었는지를 조사하였다. 양성 대조군으로서는 DEX(Dexamethasone)을 비교약물로 사용하였다. 상기 시료는 시험예 1과 같이 동결건조하여 분말로 제조한 후, 농도에 맞게 희석하여 사용하였다.The test method was to investigate whether inflammation was induced by macrophages using LPS (lipopolysaccharide) and the general inflammation index was suppressed when the sample was treated with LPS (lipopolysaccharide). As a positive control, DEX (Dexamethasone) was used as a comparative drug. The sample was lyophilized as in Test Example 1 to prepare a powder, which was diluted to a concentration.
그리고 그 결과를 도 2 내지 도 5에 나타내었다.The results are shown in Figs. 2 to 5. Fig.
도 2에서 확인할 수 있는 바와 같이, LPS로 염증 유도시 Nitrite가 크게 증가하였으나, 추출물의 처리로 인하여 증가했던 Nitrite가 감소함을 확인할 수 있었다. As can be seen from FIG. 2, Nitrite was significantly increased upon induction of inflammation by LPS, but nitrite increased by treatment of the extract.
그리고 도 3, 4, 5에서 확인할 수 있는 바와 같이, LPS로 인한 염증 유도시 cytokine이 크게 증가하였으나, 추출물의 처리로 그 염증이 완화되는 것을 확인하였다. As can be seen from FIGS. 3, 4 and 5, cytokine was significantly increased upon induction of inflammation induced by LPS, but the inflammation was alleviated by the treatment of the extract.
따라서, 상기 민들레, 엉겅퀴 뿌리 및 감초의 추출액은 농도 의존적으로 염증성 인자들의 억제효과가 있으며, 항염증 성분으로 알려진 DEX와 유사한 수준의 억제 효과가 있을 것을 판단되었다. Therefore, it was determined that the extracts of dandelion, thistle root and licorice inhibited the inflammatory factors in a concentration-dependent manner and had a similar inhibitory effect to that of DEX known as anti-inflammatory component.
(시험예 3)(Test Example 3)
훈련된 10명의 관능요원에게 시료를 평가하게 하였다. 평가항목은 외관, 맛, 향, 전체적인 기호도였고, 평가는 9점 척도법을 사용하였으며, 9에 가까울수록 극도로 좋고, 1에 가까울수록 극도로 싫은 것으로 나타내었다.Ten trained sensual agents were asked to evaluate the sample. The evaluation items were appearance, taste, incense, overall liking, and the evaluation was done using the 9 point scale method. The closer to 9, the better, and the closer to 1, the more unfavorable.
이때, 실시예 1 5g에 80℃의 물 150ml를 가하여 마시도록 하였다. 그리고 대조군으로는 시판되는 진액, 즉 엑기스 형태의 홍삼차 5g에 80℃의 물 150ml를 가한 홍삼차를 이용하였다.At this time, 150 ml of water at 80 占 폚 was added to 5 g of Example 1 to drink. As a control, red ginseng tea, which was prepared by adding 150 ml of water at 80 ° C to 5 g of commercial ginseng tea extract, namely, ginseng extract ginseng tea, was used.
상기 관능평가의 결과는 하기 표 3에 나타냈다. The results of the sensory evaluation are shown in Table 3 below.
상기 표 3에서 확인할 수 있는 바와 같이, 본 발명에 의한 실시예 1은 대조군과 비교할 때, 맛, 향에 있어서 더 우수한 평가를 받았는바, 관능성 역시 우수함을 확인할 수 있었다. As can be seen from the above Table 3, in Example 1 according to the present invention, the taste and flavor were evaluated more favorably than the control group, and the sensory evaluation was also excellent.
이상, 본 발명을 바람직한 실시예를 사용하여 상세히 설명하였으나, 본 발명의 범위는 특정 실시예에 한정되는 것은 아니며, 첨부된 특허청구범위에 의하여 해석되어야 할 것이다. 또한, 이 기술분야에서 통상의 지식을 습득한 자라면, 본 발명의 범위에서 벗어나지 않으면서도 많은 수정과 변형이 가능함을 이해하여야 할 것이다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the scope of the present invention is not limited to the disclosed exemplary embodiments. It will also be appreciated that many modifications and variations will be apparent to those skilled in the art without departing from the scope of the present invention.
Claims (5)
상기 혼합물 추출액과 상기 홍삼 추출액과 상기 팜 재거리 액은 1:0.5~1.5:0.1~1 중량비로서 이루어지며,
상기 민들레 전초, 엉겅퀴 뿌리 및 감초 뿌리를 혼합한 혼합물 추출액은,
상기 민들레 전초, 엉컹퀴 뿌리, 감초 뿌리를 100:10~20:0.5~1 중량비로 혼합하고, 이를 추출하여서 된 것이고,
상기 홍삼 추출액은 수삼을 증삼, 건조 및 숙성하고, 이를 추출하여 된 것이며,
상기 팜 재거리 액은 팜 재거리를 정제수에 용해, 농축한 후, 필터로 거른 농축액을 희석하여 된 것임을 특징으로 하는 민들레와 엉겅퀴 뿌리를 이용한 액상 차 조성물.
A mixture extract obtained by mixing a dry dandelion, a dried thistle root and a dried licorice root, a red ginseng extract, and a palm jaggery solution,
Wherein the mixture extract, the red ginseng extract, and the distillate solution are mixed at a weight ratio of 1: 0.5 to 1.5: 0.1 to 1,
The dandelion outpost, the thistle root and the licorice root mixture were mixed,
The dandelion outpost, the tilted root, and the licorice root are mixed at a weight ratio of 100: 10 to 20: 0.5 to 1,
The red ginseng extract is obtained by extracting ginseng with fresh ginseng, drying and aging,
Wherein the distillation liquid of the palm is obtained by dissolving and concentrating the distillation amount of palm in purified water and then diluting the concentrate filtered with a filter.
상기 전초를 건조한 민들레, 건조한 엉겅퀴 뿌리 및 건조한 감초 뿌리를 100:10~20:0.5~1 중량비로 혼합하고,
상기 수득한 혼합물 추출액과, 상기 홍삼 추출액과, 상기 팜 재거리 액을 1:0.5~1.5:0.1~1 중량비로 혼합하는 것을 특징으로 하는 민들레와 엉겅퀴 뿌리를 이용한 액상 차 조성물의 제조방법.Mixing dry dandelion, dried thistle root and dried licorice root with 10 to 30 times by weight water to the mixed mixture and extracting at 80 to 100 ° C for 20 to 33 hours to obtain a mixture extract , Aging the dried ginseng at 70 to 125 ° C for 90 to 220 minutes using a steamer and drying the dried ginseng at 4 to 10 ° C for 6 to 12 months, Adding water 10 to 30 times by weight to the resulting mixture and extracting it at 80 to 100 ° C for 20 to 33 hours to obtain an extract of red ginseng; dissolving the palm material in purified water, concentrating it, filtering, Diluting the distilled water to obtain a distillation solution of distillate, and mixing the distillery extract, the extract, and the distillation solution at 90 to 100 ° C,
Dried dandelion, dried thistle root and dried licorice root were mixed at a weight ratio of 100: 10 to 20: 0.5 to 1,
The method for preparing a liquid tea composition using the dandelion and thistle roots, which comprises mixing the obtained mixture extract, the red ginseng extract, and the distillation solution of palm material at a weight ratio of 1: 0.5 to 1.5: 0.1 to 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170089678A KR101884294B1 (en) | 2017-07-14 | 2017-07-14 | Liquid tea compositions comprising dandelion and thistle root extract and Method of producing thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170089678A KR101884294B1 (en) | 2017-07-14 | 2017-07-14 | Liquid tea compositions comprising dandelion and thistle root extract and Method of producing thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101884294B1 true KR101884294B1 (en) | 2018-08-30 |
Family
ID=63453395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170089678A KR101884294B1 (en) | 2017-07-14 | 2017-07-14 | Liquid tea compositions comprising dandelion and thistle root extract and Method of producing thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101884294B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102560032B1 (en) | 2022-06-28 | 2023-07-26 | 전운표 | Ice cream containing thistle and its manufacturing method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100108004A (en) * | 2009-03-27 | 2010-10-06 | 이국래 | Method for preparing a drink comprising extract of ginseng and taraxacum platycarpum |
KR20140103622A (en) | 2013-02-19 | 2014-08-27 | 재단법인 전라북도생물산업진흥원 | The method for manufacturing functional tea product made from onion skin, and the product made by the method |
KR20170037352A (en) | 2015-09-25 | 2017-04-04 | 도재남 | Liquid Red ginseng tea and Method of producing thereof |
-
2017
- 2017-07-14 KR KR1020170089678A patent/KR101884294B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100108004A (en) * | 2009-03-27 | 2010-10-06 | 이국래 | Method for preparing a drink comprising extract of ginseng and taraxacum platycarpum |
KR20140103622A (en) | 2013-02-19 | 2014-08-27 | 재단법인 전라북도생물산업진흥원 | The method for manufacturing functional tea product made from onion skin, and the product made by the method |
KR20170037352A (en) | 2015-09-25 | 2017-04-04 | 도재남 | Liquid Red ginseng tea and Method of producing thereof |
Non-Patent Citations (1)
Title |
---|
네이버 블로그에 게재된 ‘초록마을 민들레즙’ (2012.08.01.).* * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102560032B1 (en) | 2022-06-28 | 2023-07-26 | 전운표 | Ice cream containing thistle and its manufacturing method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100539861C (en) | Heat-clearing and dampness eliminating herb tea | |
KR101889752B1 (en) | Method for preparing fermentated grain syrup comprising jujube and ginger | |
KR102257307B1 (en) | Method for preparing functional tea with bud of nipa fruticans wurmb and functional tea by the method | |
KR101710193B1 (en) | Method for preparing functional grain with nipa fruticans wurmb and functional grain by the method | |
KR101539864B1 (en) | Beverage for curing of hangover | |
CN103462133B (en) | Fructose roxburgh rose juice beverage and production method thereof | |
KR20100109076A (en) | Tea controlled turning browning and carbonization by heat and method for making thereof | |
CN104026506A (en) | Health care water chestnut flour and preparation method thereof | |
KR101884294B1 (en) | Liquid tea compositions comprising dandelion and thistle root extract and Method of producing thereof | |
KR100762498B1 (en) | Preparation method of grape leaf tea and grape leaf tea prepared by the same | |
KR100883278B1 (en) | A persimmon extract and the producing method thereof | |
CN103444931B (en) | Afternoon tea bag for health preservation in spring | |
JP2006271235A (en) | Beauty and health beverage, and method for producing the same | |
CN112715709B (en) | Agilawood compound tea and preparation method thereof | |
KR101870422B1 (en) | Functional composition with nipa fruticans wurmb | |
KR102366870B1 (en) | Process for preparing fermented rice with Leonurus siviricus extract | |
KR101053064B1 (en) | Supplements for skin improvement using edible snails, eel bone and herbal medicine | |
CN106616104A (en) | Health-care rose and bur fruit juice beverage | |
KR20200117624A (en) | Hangover curing agent comprising dendropanax morbifera and method for preparation thereof | |
KR20200137842A (en) | Manufacturing method of jujube tea and jujube tea manufactured by the same | |
KR101662147B1 (en) | Chokanjang using mulberry vinegar | |
JPS63208532A (en) | Tea | |
KR101199065B1 (en) | A preparing method of noodles containing bamboo sprout and green tea leaf | |
KR101756264B1 (en) | The cudrania tricuspidate bureau composition for a beverage and a method thereof | |
KR102341886B1 (en) | A natural tea removing the effect of hangover contained the extract material in acer tegmentosum and Alnus japonica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AMND | Amendment | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |